If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't ... enough ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

The Indian market is expected to trade higher on Friday, supported by positive global cues. The Nifty futures closed slightly ...

The specialty pharma sector is leading the charge in developing life-changing solutions for rare and chronic conditions. Amid ...

Mirum Pharmaceuticals' promising pipeline and strong financials make it an attractive buy in the competitive PBC space. Click ...

Stocks that were in focus include names like SAIL, which rose 4% and Aurobindo Pharma, which gained 1% and HPCL, whose shares ...

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) major shareholder Nap B.V. Forgrowth sold 49,772 shares of the firm’s stock in a transaction dated Friday, December 20th. The shares were sold at an ...

Jefferies initiated a "buy" rating on Rocket Pharmaceuticals, based on the biotech firm's experimental gene therapies.

Ironwood Pharmaceuticals, Inc. (IRWD) stock saw a decline, ending the day at $4.45 which represents a decrease of $-0.14 or -3.05% from the prior close of $4.59. The stock opened at $4.54 and touched ...

Barclays analyst Peter Lawson assigned a Buy rating to Syndax Pharmaceuticals (SNDX – Research Report) today and set a price target of $33.00.